EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia-- H. Lundbeck and pharmaceutical products distributor Otsuka Pharmaceutical Europe said Wednesday the European Commission approved Abilify Maintena as a maintenance treatment for schizophrenia. The...